Hold Glenmark Pharma: Avinash Gupta
Avinash Gupta, Assistant Vice President Research Equity, Bonanza Portfolio Limited in an interview with ET Now talks about Glenmark Pharma.
By 
|
| Avinash Gupta, Assistant Vice President Research Equity, Bonanza Portfolio Limited in an interview with ET Now talks about Glenmark Pharma.
What would you do with the Glenmark Pharma at current levels - a big positive development probably but how would you view it?
Yes, it is definitely positive and one should hold on to the stock and we look forward to target of something like 300 for this stock in medium term.
What would you do with the Glenmark Pharma at current levels - a big positive development probably but how would you view it?
Yes, it is definitely positive and one should hold on to the stock and we look forward to target of something like 300 for this stock in medium term.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Avinash Gupta joins Dun & Bradstreet as India managing director2020-11-11T09:38:27Z- Why Avinash Gupta founded Bookmycab, scaled it up & finally sold it2015-08-09T03:22:24Z
- Govt's policies have long-term vision, but investors are expecting quick results: Avinash Gupta, Merrill Lynch2015-03-18T01:22:35Z
ADVERTISEMENT
